Internal Medicine 1101 - Internal Medicine Alert - Jan 15, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Harold L. Karpman, MD
Clinical Professor of Medicine
UCLA School of Medicine

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Ken Grauer, MD
Professor
Assistant Director
Family Practice Residency Program
University of Florida

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Authors
Jonathan Abrams, MD
Professor Medicine
Division of Cardiology
University of New Mexico
Albuquerque

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Subjects:

  • Sudden Cardiac Death
  • Statins for Heart Failure
  • Influenza A Responds to Tamiflu® Better Than Influenza B
  • Arformoterol Tartrate Inhalation Solution (Brovana)
  • Clinical Briefs By Louis Kuritzky, MD
  • ECG Review: Why is the QRS Changing?

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD and associate editors Harold L. Karpman, MD, William T. Elliott, MD, FACP, James Chan, PharmD, PhD, and Ken Grauer, MD and author Carol A. Kemper, MD, FACP report no financial relationships to this field of study. Author Jonathan Abrams, MD serves on the speakers’ bureau for Merck, Pfizer, and Parke-Davis. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2007 AHC Media. All rights reserved.